泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03347 泰格医药

未开盘 06-29 16:08:52

35.660

+1.680

+4.94%

最高36.780	最低33.820	成交量352.09万
今开34.620	昨收33.980	日振幅8.71%
总市值307.03亿	流通市值43.91亿	总股本8.61亿
成交额1.26亿	换手率2.86%	流通股本1.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":35.66,"timestamp":1782720532005,"preClose":33.98,"halted":0,"volume":3520900,"delay":0,"changeRate":0.049440847557386695,"floatShares":123124800,"shares":861000000,"eps":1.04,"marketStatus":"未开盘","change":1.68,"latestTime":"06-29 16:08:52","open":34.62,"high":36.78,"low":33.82,"amount":126097857,"amplitude":0.08711,"askPrice":35.7,"askSize":5400,"bidPrice":35.66,"bidSize":2900,"shortable":3,"etf":0,"ttmEps":1.040835,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782783000000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":33.98,"dividendRate":0.004085,"openAndCloseTimeList":[[1782696600000,1782705600000],[1782709200000,1782720000000]],"volumeRatio":1.6513141523666637,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":49.16,"timestamp":1782716400000,"preClose":45.05,"halted":0,"volume":40058500,"delay":0,"premium":"-37.10"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"1159164688","title":"港股生物医药板块反弹，荣昌生物涨超16%，创新药主线全面爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=1159164688","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159164688?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:55","pubTimestamp":1782701710,"startTime":"0","endTime":"0","summary":"6月29日，港股生物医药股集体走强，荣昌生物涨超16%，康诺亚-B、诺诚健华、康方生物均涨超12%。板块上涨主要受创新药出海、BD交易活跃及临床管线进展预期带动，资金加速回流创新药和CXO方向。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","09969","02269","03347","09995","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647034208","title":"医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2647034208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647034208?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699626,"startTime":"0","endTime":"0","summary":"消息面上，东吴证券研究指，22家CXO上市公司2026Q1实现收入、归母净利润、扣非归母净利润总额增速分别同比增长18.6%、21.9%、63.5%，业绩逐季度改善。根据医药魔方，2026Q1，国内创新药一级市场融资总金额25.9亿美元，同比上涨128.6%，2026Q1中国相关交易数量及金额涨势迅猛，总金额达614亿美元，大幅领先国外交易总金额。该机构认为，随着中国创新药在全球研发创新中的比重提升，与其配套的CXO产业链将进一步增强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","LU0181495838.USD","HK0000320264.USD","LU0588546209.SGD","03347","LU2045819591.USD","LU1880383366.USD","LU0417516902.SGD","LU2242644610.SGD","LU0140636845.USD","159938","LU0823426308.USD","02359","LU0359202008.SGD","LU0326950275.SGD","LU0516422952.EUR","LU1242518931.SGD","09939","03759","LU0417516738.SGD","HK0000306685.HKD","LU0052750758.USD","603127","BK1583","LU0979878070.USD","LU1688375341.USD","LU2125910500.SGD","BK1141","BK1161","BK0216","LU3063872942.SGD","LU0348767384.USD","01548","BK1574","LU0348825331.USD","LU0043850808.USD","06127","HK0000320223.HKD","LU1794554557.SGD","BK1191","LU0348735423.USD","HK0000306701.USD","LU0320764599.SGD","02269","LU0456846285.SGD","LU0708995583.HKD","06821","BK1576","LU1720050803.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646354910","title":"Norges Bank增持泰格医药(03347)20.45万股 每股均价约33.30港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646354910","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646354910?lang=zh_cn&edition=full","pubTime":"2026-06-26 19:34","pubTimestamp":1782473691,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，6月24日，Norges Bank增持泰格医药(03347)20.45万股，每股均价33.3003港元，总金额约为680.99万港元。增持后最新持股数目约为1004.22万股，最新持股比例为8.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK0216","BK1576","LU1820825898.SGD","LU1146622755.USD","BK0077","300347","BK1583","BK1141","BK0028","EWH","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184186957","title":"港股直击 | 部分医药股、医药外包股造好，中国抗体、康诺亚升5%，泰格医药升4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184186957","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184186957?lang=zh_cn&edition=full","pubTime":"2026-06-26 10:03","pubTimestamp":1782439382,"startTime":"0","endTime":"0","summary":"部分医药股、医药外包股造好，中国抗体、康诺亚升5%，泰格医药升4%，康龙化成升3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","03347","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646809347","title":"泰格医药（300347）披露A股股份回购进展，6月25日股价上涨1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646809347","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646809347?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:17","pubTimestamp":1782397037,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，泰格医药报收于43.86元，较前一交易日上涨1.11%，最新总市值为377.65亿元。该股当日开盘42.39元，最高44.97元，最低41.65元，成交额达12.95亿元，换手率为5.28%。公司于2026年6月25日披露H股公告-翌日披露报表，显示杭州泰格医药科技股份有限公司于当日在深圳证券交易所购回43,100股A股股份，每股购回价介乎人民币42.44元至42.78元，合计支付总额人民币1,838,028元。购回后公司已发行A股股份总数为711,053,992股，库存股份数目增至26,847,258股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU1820825898.SGD","300347","03347","BK0028","399300","BK0174","BK1576","BK1141","LU1146622755.USD","BK0216","BK0077","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118504987","title":"泰格医药：6月25日回购4.31万股股份，总额约183.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118504987","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118504987?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:45","pubTimestamp":1782377151,"startTime":"0","endTime":"0","summary":"2026年6月25日，泰格医药（03347，杭州泰格医药科技股份有限公司）发布翌日披露报表，公告当日于深圳证券交易所回购A股股份，回购数量4.31万股。根据公告，此次回购数量占回购前已发行股本的约0.0061%，回购价格区间介于人民币42.44元至42.78元不等，总涉资183.80万元。\n本次回购完成后，公司已发行股本由711,097,092股变动为711,053,992股，库藏股数增至26,847,258股。公司在公告中确认已遵守香港联合交易所有限公司证券上市规则以及相关法律法规。公告由董事叶小平签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰格医药：6月25日回购4.31万股股份，总额约183.80万元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646873929","title":"泰格医药(03347)6月25日斥资人民币183.8万元回购4.31万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646873929","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646873929?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:43","pubTimestamp":1782376983,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，于2026年6月25日，该公司斥资人民币183.8万元回购4.31万股A股股份，每股回购价人民币42.44-42.78元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CYB","BK0077","BK1583","159982","BK0174","BK0028","BK1141","CNHmain","MCNHmain","BK1576","BK0216","399300","MUCmain","300347","03347","UCmain","LU1820825898.SGD","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645895457","title":"6月24日泰格医药涨5.60%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645895457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645895457?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:46","pubTimestamp":1782290819,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日泰格医药涨5.60%，收盘报43.38元，换手率6.8%，成交量38.49万手，成交额16.7亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共110家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.6285，较上一交易日上涨1.96%，近一年下跌2.34%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","LU1146622755.USD","300347","BK0077","BK0216","BK1583","BK1141","BK1576","03347","LU1820825898.SGD","BK0174","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866019","title":"CXO概念走强 凯莱英 (06821) 涨 17.77% BIO2026大会看好中国CXO高效率优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866019","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645866019?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:17","pubTimestamp":1782271026,"startTime":"0","endTime":"0","summary":"全球生物技术领域盛会BIO2026大会于6月22日至25日在美国圣地亚哥召开，汇聚全球超20000名行业参与者，覆盖人工智能与数字健康、细胞与基因治疗等前沿领域，中国CXO企业的高效率优势备受关注。光大证券研报指，2026年6月22日至25日BIO2026大会举办，70余个国家超2万名业内人士参会，覆盖18大生物医药核心议题，凯莱英、泰格医药、博腾股份等国内CXO企业参展，英硅智能同期落地AI药物研发海外合作。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","LU0516422366.SGD","LU0326950275.SGD","LU0140636845.USD","LU0708995583.HKD","HK0000306701.USD","BK1583","LU0516422952.EUR","LU1794554557.SGD","LU0856984785.SGD","002821","LU2242644610.SGD","BK1521","LU0572944931.SGD","LU0348735423.USD","LU0039217434.USD","HK0000306685.HKD","02359","HK0000320264.USD","LU0456846285.SGD","BK1141","06821","03759","CXO","BK0239","LU3063872942.SGD","LU0348766576.USD","LU0359201612.USD","LU1328615791.USD","LU0359202008.SGD","SG9999002463.SGD","BK1576","LU0051755006.USD","LU1242518931.SGD","LU1046422090.SGD","06127","LU0043850808.USD","LU2039709279.SGD","LU0456827905.SGD","BK0132","LU1720050803.USD","LU0588546209.SGD","LU1880383366.USD","LU0327786744.USD","03347","LU0320764599.SGD","LU0052750758.USD","02269","LU0819121731.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866072","title":"CRO概念股震荡走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866072","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645866072?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:11","pubTimestamp":1782270685,"startTime":"0","endTime":"0","summary":"CRO概念股震荡走高","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243781168150.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243781168150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03759","03347","BK1576","BK1191","BK1141","06127","06821","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645653708","title":"港股异动 | CRO概念股表现强势 BIO大会凸显中国CXO全球竞争力 医药领域开放迎来新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2645653708","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645653708?lang=zh_cn&edition=full","pubTime":"2026-06-24 10:00","pubTimestamp":1782266401,"startTime":"0","endTime":"0","summary":"消息面上，BIO 2026国际生物科技大会于6月22日至25日在美国圣地亚哥召开，中国CXO企业的高效率优势得到全球认可，海外订单拓展空间进一步打开。东方证券发布研报称，从CXO景气度关键指标的最新数据来看：2026年前五个月，国内资金端、研发端、订单端多重因素共振向上，国内CXO行业高景气持续。该行认为，国内CXO公司订单充足、量价双升，随着订单执行转化，将会带来报表端大幅改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2242644610.SGD","VXUS","06821","HK0000320264.USD","LU1046422090.SGD","HK0000320223.HKD","LU1169590202.USD","BK1161","LU0052750758.USD","LU2125910500.SGD","LU0320764599.SGD","HK0000306701.USD","02359","BK1576","159938","LU2045819591.USD","09939","BK1191","LU1169589451.USD","HK0000306685.HKD","03347","01548","LU0348767384.USD","BK1574","BK4585","BK4588","BK1515","BK1141","BK4121","CXO","LU0708995583.HKD","BK1583","LU0348766576.USD","BIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645386585","title":"CRO板块活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2645386585","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645386585?lang=zh_cn&edition=full","pubTime":"2026-06-24 09:35","pubTimestamp":1782264953,"startTime":"0","endTime":"0","summary":"CRO板块领涨，上涨1.87%，其中迦南科技上涨14.81%，凯莱英上涨3.62%，太龙药业上涨2.77%，药明康德、博腾股份、泰格医药涨超2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243780700160.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243780700160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06821","03347","BK1576","BK1141","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645829608","title":"泰格医药（300347）披露A股股份回购进展，6月23日股价下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645829608","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645829608?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:38","pubTimestamp":1782207489,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，泰格医药报收于41.08元，较前一交易日下跌0.29%，最新总市值为353.71亿元。该股当日开盘40.73元，最高43.48元，最低40.57元，成交额达11.43亿元，换手率为4.79%。本次购回股份拟持作库存股份。购回后，公司已发行A股股份总数为711,097,092股，库存股份数目增至26,804,158股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300030235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0174","LU1820825898.SGD","LU1146622755.USD","BK1576","399300","159982","BK0077","300347","BK1141","03347","BK1583","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128051186","title":"泰格医药6月22日回购176.11万股，涉资约6,895.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128051186","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128051186?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:36","pubTimestamp":1782117390,"startTime":"0","endTime":"0","summary":"泰格医药（股票代码：03347）2026年6月22日发布公告，披露当日于深圳证券交易所回购A股普通股共计1,761,100股，占回购前公司已发行股本约0.247%。本次回购每股价格区间为人民币38.79元至39.98元，合计支付约人民币6,895.06万元。\n本次回购完成后，公司已发行股数由712,858,192股变更为711,097,092股，库存股数由25,043,058股增至26,804,158股，公司总股本维持在737,901,250股。\n公司确认已遵守香港联合交易所有限公司证券上市规则及当地适用法律法规。公告由董事叶小平签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰格医药6月22日回购176.11万股，涉资约6,895.06万元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645047227","title":"泰格医药(03347)6月22日耗资约6895.06万元回购176.11万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645047227","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645047227?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:34","pubTimestamp":1782117280,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)公布，2026年6月22日耗资约6895.06万元回购176.11万股A股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK1576","BK0216","BK1583","LU1146622755.USD","BK0028","LU1820825898.SGD","BK1141","03347","BK0174","399300","300347","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645095821","title":"每周股票复盘：泰格医药（300347）本周回购股份达2.0654%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645095821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645095821?lang=zh_cn&edition=full","pubTime":"2026-06-21 01:28","pubTimestamp":1781976492,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，泰格医药报收于40.12元，较上周的39.82元上涨0.75%。来自股本股东变化：截至6月16日，公司已回购股份17,783,278股，占总股本的2.0654%。交易信息汇总6月15日泰格医药发生2笔大宗交易，成交金额2492.46万元。公司公告汇总杭州泰格医药科技股份有限公司于2026年5月13日及6月9日审议通过回购公司股份方案，计划以自有或自筹资金回购A股股份，用于股权激励、员工持股或注销减资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0174","LU1820825898.SGD","LU1146622755.USD","BK1576","BK0077","300347","BK1141","03347","BK1583","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644070190","title":"泰格医药（300347）披露A股股份回购进展，6月18日股价下跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644070190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644070190?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:32","pubTimestamp":1781775149,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，泰格医药报收于40.12元，较前一交易日下跌0.17%，最新总市值为345.44亿元。该股当日开盘40.0元，最高40.88元，最低39.3元，成交额达7.77亿元，换手率为3.42%。本次购回股份拟持作库存股份。购回后已发行股份总数未变，其中已发行股份由714,234,192股减少至713,400,592股，库存股份数目由23,667,058股增加至24,500,658股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800030891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1576","BK1583","03347","BK0216","BK1141","300347","BK0077","159982","LU1146622755.USD","399300","LU1820825898.SGD","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127060468","title":"泰格医药回购54.24万股股份，耗资约2,161.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127060468","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127060468?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:52","pubTimestamp":1781772738,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司于2026年6月18日发布公告，披露了最新股份回购及已发行股本变动情况。公告显示，公司于2026年6月18日通过深圳证券交易所回购股份54.24万股，占当日前已发行股份约0.076%，回购价格区间为每股人民币39.33元至39.98元，共计耗资约2,161.63万元。本次回购完成后，截至2026年6月18日，公司已发行股份降至712,858,192股，库藏股增至25,043,058股，已发行总股本保持737,901,250股不变。本次公告由公司董事叶小平签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"泰格医药回购54.24万股股份，耗资约2,161.63万元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644062337","title":"泰格医药(03347)6月18日斥资2161.63万元回购54.24万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644062337","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644062337?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:50","pubTimestamp":1781772624,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，于2026年6月18日，该公司斥资2161.63万元回购54.24万股A股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1820825898.SGD","300347","BK1576","BK0216","BK1583","BK0174","399300","159982","LU1146622755.USD","03347","BK0028","BK0077","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644703956","title":"百亿基金经理调仓路径出炉：张坤增聘共管后新布局，葛兰谢治宇反向操作","url":"https://stock-news.laohu8.com/highlight/detail?id=2644703956","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644703956?lang=zh_cn&edition=full","pubTime":"2026-06-18 15:50","pubTimestamp":1781769000,"startTime":"0","endTime":"0","summary":"随着近期上市公司股东名单密集披露，百亿基金经理二季度调仓路径逐渐清晰。具体来看，易方达基金张坤的代表作基金——易方达蓝筹精选，在增聘基金经理杨思亮、何一铖共管后，首次建仓广深铁路。与此同时，中欧基金葛兰与兴证全球基金谢治宇在泰格医药上反向而行；景顺长城基金刘彦春与大成基金徐彦对晨光股份的调仓路径同样彼此背离，永赢基金高楠则对嘉益股份进行了微调。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606183776128689.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606183776128689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1820825898.SGD","BK0183","BK0216","BK0239","03347","BK0174","BK0187","BK0028","BK0196","BK1576","BK1141","BK0188","BK0077","BK1583","002294","300347","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":0.1263},{"period":"1month","weight":0.1579},{"period":"3month","weight":-0.1355},{"period":"6month","weight":-0.1578},{"period":"1year","weight":0.005},{"period":"ytd","weight":-0.1578}],"compareEarnings":[{"period":"1week","weight":-0.0312},{"period":"1month","weight":-0.0856},{"period":"3month","weight":-0.0711},{"period":"6month","weight":-0.1016},{"period":"1year","weight":-0.0518},{"period":"ytd","weight":-0.1016}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家主要从事为新药研发提供临床试验全过程专业服务的中国公司。该公司提供服务主要包括临床试验技术服务和临床试验相关及实验室服务。临床试验技术服务提供创新药物、仿制药及医疗器械临床试验运营服务以及与临床试验直接相关的配套服务，包括临床运营、临床药理、注册与法规事务、科学事务等服务。临床试验相关及实验室服务提供在药物开发过程中的相关及实验室服务，包括数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室等服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.032258},{"month":2,"riseRate":0.5,"avgChangeRate":0.003409},{"month":3,"riseRate":0.5,"avgChangeRate":-0.032695},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.051086},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.017912},{"month":6,"riseRate":0.666667,"avgChangeRate":0.046922},{"month":7,"riseRate":0.6,"avgChangeRate":0.079522},{"month":8,"riseRate":0,"avgChangeRate":-0.091856},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032062},{"month":10,"riseRate":0.5,"avgChangeRate":-0.025938},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001369},{"month":12,"riseRate":0.5,"avgChangeRate":0.041242}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}